Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder

References

• Tatarczyńska E, Klodzińska A, Chojnacka-Wójcik E, et al. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol. 2001;132(7):1423–1430. doi:10.1038/sj.bjp.0703923
   PubMed Web of Science ®Google Scholar
• Li X, Need AB, Baez M, Witkin JM. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. J Pharmacol Exp Ther. 2006;319(1):254–259. doi:10.1124/jpet.106.103143
   PubMed Web of Science ®Google Scholar
• Belozertseva IV, Kos T, Popik P, Danysz W, Bespalov AY. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur Neuropsychopharmacol. 2007;17(3):172–179. doi:10.1016/j.euroneuro.2006.03.002
   PubMed Web of Science ®Google Scholar
• Deschwanden A, Karolewicz B, Feyissa A, et al. Reduced metabotropic glutamate receptor 5 density in major depression determined by [C-11]ABP688 PET and postmortem study. Am J Psychiatry. 2011;168:727–734. doi:10.1176/appi.ajp.2011.09111607
   PubMed Web of Science ®Google Scholar
• Kovačević T, Skelin I, Minuzzi L, Rosa-Neto P, Diksic M. Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study. Brain Res Bull. 2012;87(4–5):406–412. doi:10.1016/j.brainresbull.2012.01.010
   Web of Science ®Google Scholar
• Kim JH, Joo YH, Son YD, et al. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression. Eur Neuropsychopharmacol. 2019;29(2):278–290. doi:10.1016/j.euroneuro.2018.12.001
   Web of Science ®Google Scholar
• DeLorenzo C, Sovago J, Gardus J, et al. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [11C]ABP688. Transl Psychiatry. 2015;5:e693. doi:10.1038/tp.2015.189
   Web of Science ®Google Scholar
• Abdallah CG, Hannestad J, Mason GF, et al. Metabotropic glutamate receptor 5 and glutamate involvement in major depressive disorder: a multimodal imaging study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(5):449–456. doi:10.1016/j.bpsc.2017.03.019
   PubMedGoogle Scholar
• Esterlis I, Holmes SE, Sharma P, Krystal JH, DeLorenzo C. mGluR5 and stress disorders: knowledge gained from receptor imaging studies. Biol Psychiatry. 2018;84(2):95–105. doi:10.1016/j.biopsych.2017.08.025
   Web of Science ®Google Scholar
• Ohayon MM, Schatzberg AF. Social phobia and depression: prevalence and comorbidity. J Psychosom Res. 2010;68(3):235–243. doi:10.1016/j.jpsychores.2009.07.018
   PubMed Web of Science ®Google Scholar
• Stein MB, Chavira DA. Subtypes of social phobia and comorbidity with depression and other anxiety disorders. J Affect Disord. 1998;50(Suppl 1):S11–16. doi:10.1016/s0165-0327(98)00092-5
   Web of Science ®Google Scholar
• Alpert JE, Uebelacker LA, McLean NE, et al. Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications. Psychol Med. 1997;27(3):627–633. doi:10.1017/s0033291797004765
   Web of Science ®Google Scholar
• Liebowitz MR, Gorman JM, Fyer AJ, Klein DF. Social phobia. Review of a neglected anxiety disorder. Arch Gen Psychiatry. 1985;42(7):729–736. doi:10.1001/archpsyc.1985.01790300097013
   PubMed Web of Science ®Google Scholar
• Slattery DA, Neumann ID, Flor PJ, Zoicas I. Pharmacological modulation of metabotropic glutamate receptor subtype 5 and 7 impairs extinction of social fear in a time-point-dependent manner. Behav Brain Res. 2017;328:57–61. doi:10.1016/j.bbr.2017.04.010
   Web of Science ®Google Scholar
• Schulz B, Fendt M, Gasparini F, Lingenhöhl K, Kuhn R, Koch M. The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacology. 2001;41(1):1–7. doi:10.1016/s0028-3908(01)00036-3
   Web of Science ®Google Scholar
• Rodrigues SM, Bauer EP, Farb CR, Schafe GE, LeDoux JE. The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala. J Neurosci. 2002;22(12):5219–5229. doi:10.1523/JNEUROSCI.22-12-05219.2002
   Web of Science ®Google Scholar
• Xu J, Zhu Y, Contractor A, Heinemann SF. mGluR5 has a critical role in inhibitory learning. J Neurosci. 2009;29(12):3676–3684. doi:10.1523/JNEUROSCI.5716-08.2009
   Web of Science ®Google Scholar
• Jacob W, Gravius A, Pietraszek M, et al. The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning. Neuropharmacology. 2009;57(2):97–108. doi:10.1016/j.neuropharm.2009.04.011
   PubMed Web of Science ®Google Scholar
• Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron. 2007;53(6):871–880. doi:10.1016/j.neuron.2007.02.021
   PubMed Web of Science ®Google Scholar
• Ametamey SM, Treyer V, Streffer J, et al. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. J Nucl Med. 2007;48(2):247–252.
   Web of Science ®Google Scholar
• Wang J, Tian Y, Zeng LH, Xu H. Prefrontal disinhibition in social fear: a vital action of somatostatin interneurons. Front Cell Neurosci. 2020;14:611732. doi:10.3389/fncel.2020.611732
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
   Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I). New York: Biometrics Research. New York State Psychiatric Institute; 1996.
   Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi:10.1136/jnnp.23.1.56
   PubMed Web of Science ®Google Scholar
• Beck AT. Depression. Clinical, Experimental and Theoretical Aspects. New York (Hoeber). 1967.
   Google Scholar
• Watson D, Friend R. Measurement of social-evaluative anxiety. J Consult Clin Psychol. 1969;33(4):448–457. doi:10.1037/h0027806
   PubMed Web of Science ®Google Scholar
• Lee JY, Choi CH. A study of the reliability and the validity of the Korean versions of Social Phobia Scales (K-SAD, K-FNE). Korean J Clin Psychol. 1997;16(2):251–264.
   Google Scholar
• DeLorenzo C, Kumar JSD, Mann JJ, Parsey RV. In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688. J Cereb Blood Flow Metab. 2011;31(11):2169–2180. doi:10.1038/jcbfm.2011.105
   Web of Science ®Google Scholar
• DeLorenzo C, Gallezot JD, Gardus J, et al. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [11C]ABP688 and [18F]FPEB. J Cereb Blood Flow Metab. 2017;37(8):2716–2727. doi:10.1177/0271678X16673646
   Web of Science ®Google Scholar
• Wu Y, Carson RE. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J Cereb Blood Flow Metab. 2002;22(12):1440–1452. doi:10.1097/01.WCB.0000033967.83623.34
   Web of Science ®Google Scholar
• DuBois JM, Rousset OG, Rowley J, et al. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET. Eur J Nucl Med Mol Imaging. 2016;43(1):152–162. doi:10.1007/s00259-015-3167-6
   Web of Science ®Google Scholar
• Akkus F, Treyer V, Ametamey SM, Johayem A, Buck A, Hasler G. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia. Schizophr Res. 2017;183:95–101. doi:10.1016/j.schres.2016.11.008
   PubMed Web of Science ®Google Scholar
• Akkus F, Mihov Y, Treyer V, et al. Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder. Transl Psychiatry. 2018;8(1):17. doi:10.1038/s41398-017-0066-6
   Web of Science ®Google Scholar
• Smart K, Cox SML, Nagano-Saito A, Rosa-Neto P, Leyton M, Benkelfat C. Test-retest variability of [11 C]ABP688 estimates of metabotropic glutamate receptor subtype 5 availability in humans. Synapse. 2018;72(9):e22041. doi:10.1002/syn.22041
   Web of Science ®Google Scholar
• Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage. 2002;15(1):273–289. doi:10.1006/nimg.2001.0978
   PubMed Web of Science ®Google Scholar
• Bruder GE, Stewart JW, McGrath PJ. Right brain, left brain in depressive disorders: clinical and theoretical implications of behavioral, electrophysiological and neuroimaging findings. Neurosci Biobehav Rev. 2017;78:178–191. doi:10.1016/j.neubiorev.2017.04.021
   PubMed Web of Science ®Google Scholar
• de Aguiar Neto FS, Rosa JLG. Depression biomarkers using non-invasive EEG: a review. Neurosci Biobehav Rev. 2019;105:83–93. doi:10.1016/j.neubiorev.2019.07.021
   PubMed Web of Science ®Google Scholar
• Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov. 2005;4(2):131–144. doi:10.1038/nrd1630
   PubMed Web of Science ®Google Scholar
• Terbeck S, Akkus F, Chesterman LP, Hasler G. The role of metabotropic glutamate receptor 5 in the pathogenesis of mood disorders and addiction: combining preclinical evidence with human Positron Emission Tomography (PET) studies. Front Neurosci. 2015;9:86. doi:10.3389/fnins.2015.00086
   PubMed Web of Science ®Google Scholar
• Gravius A, Pietraszek M, Schmidt WJ, Danysz W. Functional interaction of NMDA and group I metabotropic glutamate receptors in negatively reinforced learning in rats. Psychopharmacology. 2006;185(1):58–65. doi:10.1007/s00213-005-0249-3
   Web of Science ®Google Scholar
• Molina-Hernández M, Tellez-Alcántara NP, Pérez-García J, Olivera-Lopez JI, Jaramillo MT. Antidepressant-like and anxiolytic-like actions of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of male Wistar rats. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6):1129–1135. doi:10.1016/j.pnpbp.2006.04.022
   Web of Science ®Google Scholar
• Chen L, Liu J, Ali U, et al. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions. Brain Res Bull. 2011;84(3):215–223. doi:10.1016/j.brainresbull.2011.01.005
   Web of Science ®Google Scholar
• Fontanez-Nuin DE, Santini E, Quirk GJ, Porter JT. Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons. Cereb Cortex. 2011;21(3):727–735. doi:10.1093/cercor/bhq147
   Web of Science ®Google Scholar
• Iijima M, Fukumoto K, Chaki S. Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test. Behav Brain Res. 2012;235(2):287–292. doi:10.1016/j.bbr.2012.08.016
   Web of Science ®Google Scholar
• Chung W, Choi SY, Lee E, et al. Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression. Nat Neurosci. 2015;18(3):435–443. doi:10.1038/nn.3927
   PubMed Web of Science ®Google Scholar
• Wagner KV, Hartmann J, Labermaier C, et al. Homer1/mGluR5 activity moderates vulnerability to chronic social stress. Neuropsychopharmacology. 2015;40(5):1222–1233. doi:10.1038/npp.2014.308
   Web of Science ®Google Scholar
• Xu H, Liu L, Tian Y, et al. A disinhibitory microcircuit mediates conditioned social fear in the prefrontal cortex. Neuron. 2019;102(3):668–682.e5. doi:10.1016/j.neuron.2019.02.026
   Web of Science ®Google Scholar
• Bittar TP, Labonté B. Functional contribution of the medial prefrontal circuitry in major depressive disorder and stress-induced depressive-like behaviors. Front Behav Neurosci. 2021;15. doi:10.3389/fnbeh.2021.699592
   Web of Science ®Google Scholar
• Pinkham AE, Hopfinger JB, Pelphrey KA, Piven J, Penn DL. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr Res. 2008;99(1–3):164–175. doi:10.1016/j.schres.2007.10.024
   PubMed Web of Science ®Google Scholar
• Rassovsky Y, Dunn W, Wynn J, et al. The effect of transcranial direct current stimulation on social cognition in schizophrenia: a preliminary study. Schizophr Res. 2015;165(2–3):171–174. doi:10.1016/j.schres.2015.04.016
   PubMed Web of Science ®Google Scholar
• Shin JE, Choi SH, Lee H, Shin YS, Jang DP, Kim JJ. Involvement of the dorsolateral prefrontal cortex and superior temporal sulcus in impaired social perception in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2015;58:81–88. doi:10.1016/j.pnpbp.2014.12.006
   PubMed Web of Science ®Google Scholar
• Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A. 2003;100(1):253–258. doi:10.1073/pnas.0135058100
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Oxley TJ, Laird AR, Kulkarni J, Egan GF, Daskalakis ZJ. An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res. 2006;148(1):33–45. doi:10.1016/j.pscychresns.2006.04.006
   Web of Science ®Google Scholar
• Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64(2):193–200. doi:10.1001/archpsyc.64.2.193
   PubMed Web of Science ®Google Scholar
• Johnstone T, van Reekum CM, Urry HL, Kalin NH, Davidson RJ. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J Neurosci. 2007;27(33):8877–8884. doi:10.1523/JNEUROSCI.2063-07.2007
   PubMed Web of Science ®Google Scholar
• Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry. 2007;61(2):198–209. doi:10.1016/j.biopsych.2006.05.048
   PubMed Web of Science ®Google Scholar
• Sheline YI, Barch DM, Price JL, et al. The default mode network and self-referential processes in depression. PNAS. 2009;106(6):1942–1947. doi:10.1073/pnas.0812686106
   PubMed Web of Science ®Google Scholar
• Sheline YI, Price JL, Yan Z, Mintun MA. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci U S A. 2010;107(24):11020–11025. doi:10.1073/pnas.1000446107
   PubMed Web of Science ®Google Scholar
• Gellner AK, Voelter J, Schmidt U, et al. Molecular and neurocircuitry mechanisms of social avoidance. Cell Mol Life Sci. 2021;78(4):1163–1189. doi:10.1007/s00018-020-03649-x
   Web of Science ®Google Scholar
• Davis MT, Hillmer A, Holmes SE, et al. In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation. Proc Natl Acad Sci U S A. 2019;116(23):11490–11495. doi:10.1073/pnas.1818871116
   PubMed Web of Science ®Google Scholar
• DeLorenzo C, Milak MS, Brennan KG, Kumar JSD, Mann JJ, Parsey RV. In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons. Eur J Nucl Med Mol Imaging. 2011;38(6):1083–1094. doi:10.1007/s00259-010-1723-7
   Web of Science ®Google Scholar
• Daggett LP, Sacaan AI, Akong M, et al. Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5. Neuropharmacology. 1995;34(8):871–886. doi:10.1016/0028-3908(95)00085-k
   Web of Science ®Google Scholar
• Berthele A, Platzer S, Laurie DJ, et al. Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum. Neuroreport. 1999;10(18):3861–3867. doi:10.1097/00001756-199912160-00026
   PubMed Web of Science ®Google Scholar
• Patel S, Hamill TG, Connolly B, Jagoda E, Li W, Gibson RE. Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB. Nucl Med Biol. 2007;34(8):1009–1017. doi:10.1016/j.nucmedbio.2007.07.009
   Web of Science ®Google Scholar